BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea · Delayed Price · Currency is KRW 1,580.00
-54.00 (-3.30%)
At close: Jul 20, 2026
BioInfra Market Cap
BioInfra has a market cap or net worth of 8.07 billion as of July 21, 2026. Its market cap has decreased by -70.14% in one year.
Market Cap
8.07B
Enterprise Value
12.49B
Revenue
23.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,580.00
ChartMarket Cap Chart
Since March 2, 2023, BioInfra's market cap has decreased from 141.03B to 8.07B, a decrease of -94.27%. That is a compound annual growth rate of -57.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 8.07B | -64.90% |
| Dec 30, 2025 | 23.01B | -26.09% |
| Dec 30, 2024 | 31.13B | -46.41% |
| Dec 28, 2023 | 58.09B | -58.81% |
| Mar 2, 2023 | 141.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 227.27B |
| DreamCIS | 69.62B |
| P&K Skin Research Center | 50.20B |
| WOOJUNG BIO | 42.49B |
| HLB bioStep | 32.57B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 22.19B |
| C&R Research | 21.83B |